Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Cervical Cancer | Research

Sociodemographic characteristics and their association with survival in women with cervical cancer

Authors: Lucely Cetina-Pérez, Julissa Luvián-Morales, Merari Delgadillo-González, Denisse Castro-Eguiluz, Tatiana Galicia-Carmona, Kely Rely, Rita Vaca González, Gabriela Lugo-Martínez, Nadia García-Barrientos, Antonio Nateras

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

In 2020, the highest incidence and mortality from cervical cancer (CC) were detected in low and middle-income countries. CC remains a health problem for women living in them. In Mexico, CC ranks second in cancer incidence and mortality in women. The main characteristics of this population are low income, low educational level, and inadequate medical coverage. The present study characterized the Mexican population by CC, and the sociodemographic variables that impacted overall survival (OS) were identified.

Methods

A retrospective study that included a cohort of patients with a confirmed diagnosis of CC at the Instituto Nacional de Cancerologia between 2003 and 2016. Information was collected on sociodemographic variables related to the disease and OS.

Results

Four thousand six hundred thirty-one patients were included. The median age was 51 years, 78.5% were unemployed, 44.4% lived in a rural/suburban area, 50.8% had a partner when collecting this information, and 74.3% were classified as having low socioeconomic status. Age, living in a rural/suburban area, more advanced stages of the disease, and not receiving cancer treatment were associated with lower OS.

Conclusion

CC continues to affect mainly women with minimal resources, low educational levels, and living in marginalized areas. These characteristics influence the OS. Prevention and timely detection programs, education, and training focused on this population and with broader coverage are required to identify patients with CC at earlier stages.
Literature
1.
go back to reference Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. France: International Agency for Research on Cancer. (2020). https://gco.iarc.fr/today. [Accessed 10 Nov 2022]. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. France: International Agency for Research on Cancer. (2020). https://​gco.​iarc.​fr/​today. [Accessed 10 Nov 2022].
2.
go back to reference Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle income countries (Review). Oncol Lett. 2020;20:2058–74.CrossRefPubMedPubMedCentral Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle income countries (Review). Oncol Lett. 2020;20:2058–74.CrossRefPubMedPubMedCentral
4.
go back to reference Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortés-Gutiérrez EI, Salgado-Bernabé ME, Ramos-González NP, Ortega-Cervantes L, et al. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections. J Med Virol. 2015;87:871–84.CrossRefPubMed Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortés-Gutiérrez EI, Salgado-Bernabé ME, Ramos-González NP, Ortega-Cervantes L, et al. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections. J Med Virol. 2015;87:871–84.CrossRefPubMed
5.
go back to reference Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect. 2013;66:207–17.CrossRefPubMed Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect. 2013;66:207–17.CrossRefPubMed
6.
go back to reference Roik E, Sharashova E, Kharkova O, Nieboer E, Postoev V, Odland J. Sociodemographic characteristics, sexual behaviour and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk. North-West Russia Int J Circumpolar Health. 2018;77:1498681.CrossRefPubMed Roik E, Sharashova E, Kharkova O, Nieboer E, Postoev V, Odland J. Sociodemographic characteristics, sexual behaviour and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk. North-West Russia Int J Circumpolar Health. 2018;77:1498681.CrossRefPubMed
7.
go back to reference Isla-Ortiz D, Palomares-Castillo E, Mille-Loera JE, Ramírez-Calderón N, Mohar-Betancourt A, Meneses-García AA, et al. Cervical cancer in young women: do they have a worse prognosis? a retrospective cohort analysis in a population of Mexico. Oncologist. 2020;25:e1363–71.CrossRefPubMedPubMedCentral Isla-Ortiz D, Palomares-Castillo E, Mille-Loera JE, Ramírez-Calderón N, Mohar-Betancourt A, Meneses-García AA, et al. Cervical cancer in young women: do they have a worse prognosis? a retrospective cohort analysis in a population of Mexico. Oncologist. 2020;25:e1363–71.CrossRefPubMedPubMedCentral
8.
go back to reference Torreglosa-Hernández S, Grisales-Romero H, Morales-Carmona E, Hernández-Ávila JE, Huerta-Gutiérrez R, Barquet-Muñoz SA, et al. Survival analysis and associated factors in patients with cervical cancer financed by the Seguro Popular in Mexico. Salud Publica Mex. 2022;64:76–86.CrossRefPubMed Torreglosa-Hernández S, Grisales-Romero H, Morales-Carmona E, Hernández-Ávila JE, Huerta-Gutiérrez R, Barquet-Muñoz SA, et al. Survival analysis and associated factors in patients with cervical cancer financed by the Seguro Popular in Mexico. Salud Publica Mex. 2022;64:76–86.CrossRefPubMed
10.
go back to reference Benavidez GA, Zgodic A, Zahnd WE, Eberth JM. Disparities in meeting USPSTF breast, cervical, and colorectal cancer screening guidelines among women in the United States. Prev Chronic Dis. 2021;18:E37.CrossRefPubMedPubMedCentral Benavidez GA, Zgodic A, Zahnd WE, Eberth JM. Disparities in meeting USPSTF breast, cervical, and colorectal cancer screening guidelines among women in the United States. Prev Chronic Dis. 2021;18:E37.CrossRefPubMedPubMedCentral
11.
go back to reference Simkin J, Smith L, van Niekerk D, Caird H, Dearden T, van der Hoek K, et al. Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004–2013: a descriptive study. CMAJ Open. 2021;9:E424–32.CrossRefPubMedPubMedCentral Simkin J, Smith L, van Niekerk D, Caird H, Dearden T, van der Hoek K, et al. Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004–2013: a descriptive study. CMAJ Open. 2021;9:E424–32.CrossRefPubMedPubMedCentral
12.
go back to reference Gómez Dantés O, Ortiz M. Seguro popular de salud siete perspectivas. Salud Publica Mex. 2004;46:585–8.CrossRefPubMed Gómez Dantés O, Ortiz M. Seguro popular de salud siete perspectivas. Salud Publica Mex. 2004;46:585–8.CrossRefPubMed
13.
go back to reference Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer. 2003;13:657–63.CrossRefPubMed Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer. 2003;13:657–63.CrossRefPubMed
14.
go back to reference Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynecol Obstet. 2009;105:107–8.CrossRef Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynecol Obstet. 2009;105:107–8.CrossRef
16.
go back to reference Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale. Cancer. 1984;53:2002–7.CrossRefPubMed Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale. Cancer. 1984;53:2002–7.CrossRefPubMed
17.
go back to reference Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17:5–19.CrossRefPubMed Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17:5–19.CrossRefPubMed
18.
go back to reference Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. IARC Sci Publ. 1997;138:377–97. Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. IARC Sci Publ. 1997;138:377–97.
19.
go back to reference Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-ávila M. Diferencias regionales en la mortalidad por cáncer de mama y cérvix en méxico entre 1979 y 2006. Salud Publica Mex. 2009;51(Suppl 2):s208–19.CrossRefPubMed Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-ávila M. Diferencias regionales en la mortalidad por cáncer de mama y cérvix en méxico entre 1979 y 2006. Salud Publica Mex. 2009;51(Suppl 2):s208–19.CrossRefPubMed
20.
go back to reference Villalobos CM, Wendling CC, Sierra HC, Valencia CO, Cárcamo IM, Gayán PP. Supervivencia de cáncer cervicouterino escamoso y adenocarcinoma en pacientes atendidas en el Instituto Nacional del Cáncer, 2009–2013. Gac Mex Oncol. 2016;15:263–7. Villalobos CM, Wendling CC, Sierra HC, Valencia CO, Cárcamo IM, Gayán PP. Supervivencia de cáncer cervicouterino escamoso y adenocarcinoma en pacientes atendidas en el Instituto Nacional del Cáncer, 2009–2013. Gac Mex Oncol. 2016;15:263–7.
21.
go back to reference Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y. Survival of women with breast cancer in Ottawa, Canada: Variation with age, stage, histology, grade and treatment. Br J Cancer. 2004;90:1138–43.CrossRefPubMedPubMedCentral Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y. Survival of women with breast cancer in Ottawa, Canada: Variation with age, stage, histology, grade and treatment. Br J Cancer. 2004;90:1138–43.CrossRefPubMedPubMedCentral
22.
go back to reference Gauri A, Messiah SE, Bouzoubaa LA, Moore KJ, Koru-Sengul T. Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981–2013) by stage at presentation. Ethn Heal. 2020;25:995–1003.CrossRef Gauri A, Messiah SE, Bouzoubaa LA, Moore KJ, Koru-Sengul T. Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981–2013) by stage at presentation. Ethn Heal. 2020;25:995–1003.CrossRef
23.
go back to reference Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR. Cervical cancer survival by socioeconomic status race/ethnicity, and place of residence in Texas, 1995–2001. J Womens Health. 2006;15:941–51.CrossRef Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR. Cervical cancer survival by socioeconomic status race/ethnicity, and place of residence in Texas, 1995–2001. J Womens Health. 2006;15:941–51.CrossRef
25.
go back to reference Lau HY, Juang CM, Chen YJ, Twu NF, Yen MS, Chao KC. Aggressive characteristics of cervical cancer in young women in Taiwan. Int J Gynecol Obstet. 2009;107:220–3.CrossRef Lau HY, Juang CM, Chen YJ, Twu NF, Yen MS, Chao KC. Aggressive characteristics of cervical cancer in young women in Taiwan. Int J Gynecol Obstet. 2009;107:220–3.CrossRef
26.
go back to reference Pelkofski E, Stine J, Wages NA, Gehrig PA, Kim KH, Cantrell LA. Cervical cancer in women aged 35 years and younger. Clin Ther. 2016;38:459–66.CrossRefPubMed Pelkofski E, Stine J, Wages NA, Gehrig PA, Kim KH, Cantrell LA. Cervical cancer in women aged 35 years and younger. Clin Ther. 2016;38:459–66.CrossRefPubMed
27.
go back to reference Soneji S, Fukui N. Socioeconomic determinants of cervical cancer screening in Latin America. Rev Panam Salud Publica. 2013;33:174–82.CrossRefPubMed Soneji S, Fukui N. Socioeconomic determinants of cervical cancer screening in Latin America. Rev Panam Salud Publica. 2013;33:174–82.CrossRefPubMed
28.
go back to reference Brun JL, Stoven-Camou D, Trouette R, Lopez M, Chene G, Hocké C. Survival and prognosis of women with invasive cervical cancer according to age. Gynecol Oncol. 2003;91:395–401.CrossRefPubMed Brun JL, Stoven-Camou D, Trouette R, Lopez M, Chene G, Hocké C. Survival and prognosis of women with invasive cervical cancer according to age. Gynecol Oncol. 2003;91:395–401.CrossRefPubMed
29.
go back to reference Sharma C, Deutsch I, Horowitz DP, Hershman DL, Lewin SN, Lu YS, et al. Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer. 2012;118:3618–26.CrossRefPubMed Sharma C, Deutsch I, Horowitz DP, Hershman DL, Lewin SN, Lu YS, et al. Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer. 2012;118:3618–26.CrossRefPubMed
30.
go back to reference Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353:1127–31.CrossRefPubMed Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353:1127–31.CrossRefPubMed
31.
go back to reference Li X, Sundquist J, Calling S, Zöller B, Sundquist K. Neighborhood deprivation and risk of cervical cancer morbidity and mortality: a multilevel analysis from Sweden. Gynecol Oncol. 2012;127:283–9.CrossRefPubMed Li X, Sundquist J, Calling S, Zöller B, Sundquist K. Neighborhood deprivation and risk of cervical cancer morbidity and mortality: a multilevel analysis from Sweden. Gynecol Oncol. 2012;127:283–9.CrossRefPubMed
32.
go back to reference Lu DJ, Atkins KM, Small W, Kamrava M. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost. Brachytherapy. 2022;21:22–8.CrossRefPubMed Lu DJ, Atkins KM, Small W, Kamrava M. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost. Brachytherapy. 2022;21:22–8.CrossRefPubMed
33.
go back to reference Tiraki Z, Yılmaz M. Cervical cancer knowledge, self-efficacy, and health literacy levels of married women. J Cancer Educ. 2018;33:1270–8.CrossRefPubMed Tiraki Z, Yılmaz M. Cervical cancer knowledge, self-efficacy, and health literacy levels of married women. J Cancer Educ. 2018;33:1270–8.CrossRefPubMed
34.
go back to reference Wakwoya EB, Gemechu KS, Dasa TT. Knowledge of cervical cancer and associated factors among women attending public health facilities in eastern Ethiopia. Cancer Manag Res. 2020;12:10103–11.CrossRefPubMedPubMedCentral Wakwoya EB, Gemechu KS, Dasa TT. Knowledge of cervical cancer and associated factors among women attending public health facilities in eastern Ethiopia. Cancer Manag Res. 2020;12:10103–11.CrossRefPubMedPubMedCentral
36.
go back to reference Polednak AP. Survival of breast cancer patients in Connecticut in relation to socioeconomic and health care access indicators. J Urban Health. 2002;79:211–8.CrossRefPubMedPubMedCentral Polednak AP. Survival of breast cancer patients in Connecticut in relation to socioeconomic and health care access indicators. J Urban Health. 2002;79:211–8.CrossRefPubMedPubMedCentral
37.
go back to reference Macleod U, Ross S, Fallowfield L, Watt GCM. Anxiety and support in breast cancer: Is this different for affluent and deprived women? a questionnaire study. Br J Cancer. 2004;91:879–83.CrossRefPubMedPubMedCentral Macleod U, Ross S, Fallowfield L, Watt GCM. Anxiety and support in breast cancer: Is this different for affluent and deprived women? a questionnaire study. Br J Cancer. 2004;91:879–83.CrossRefPubMedPubMedCentral
38.
go back to reference McDonald YJ, Goldberg DW, Scarinci IC, Castle PE, Cuzick J, Robertson M, et al. Health service accessibility and risk in cervical cancer prevention: comparing rural versus nonrural residence in new Mexico. J Rural Heal. 2017;33:382–92.CrossRef McDonald YJ, Goldberg DW, Scarinci IC, Castle PE, Cuzick J, Robertson M, et al. Health service accessibility and risk in cervical cancer prevention: comparing rural versus nonrural residence in new Mexico. J Rural Heal. 2017;33:382–92.CrossRef
39.
go back to reference Van Der Aa MA, Siesling S, Louwman MW, Visser O, Pukkala E, Coebergh JWW. Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989–2003. Eur J Cancer Prev. 2008;17:453–9.CrossRefPubMed Van Der Aa MA, Siesling S, Louwman MW, Visser O, Pukkala E, Coebergh JWW. Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989–2003. Eur J Cancer Prev. 2008;17:453–9.CrossRefPubMed
40.
go back to reference Park MJ, Park EC, Choi KS, Jun JK, Lee HY. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005–2009. BMC Cancer. 2011;11:257.CrossRefPubMedPubMedCentral Park MJ, Park EC, Choi KS, Jun JK, Lee HY. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005–2009. BMC Cancer. 2011;11:257.CrossRefPubMedPubMedCentral
41.
go back to reference Bermedo-Carrasco S, Waldner CL. The role of socio-demographic factors in premature cervical cancer mortality in Colombia. BMC Public Health. 2016;16:981.CrossRefPubMedPubMedCentral Bermedo-Carrasco S, Waldner CL. The role of socio-demographic factors in premature cervical cancer mortality in Colombia. BMC Public Health. 2016;16:981.CrossRefPubMedPubMedCentral
42.
go back to reference Afshar N, English DR, Milne RL. Rural–urban residence and cancer survival in high-income countries: a systematic review. Cancer. 2019;125:2172–84.CrossRefPubMed Afshar N, English DR, Milne RL. Rural–urban residence and cancer survival in high-income countries: a systematic review. Cancer. 2019;125:2172–84.CrossRefPubMed
Metadata
Title
Sociodemographic characteristics and their association with survival in women with cervical cancer
Authors
Lucely Cetina-Pérez
Julissa Luvián-Morales
Merari Delgadillo-González
Denisse Castro-Eguiluz
Tatiana Galicia-Carmona
Kely Rely
Rita Vaca González
Gabriela Lugo-Martínez
Nadia García-Barrientos
Antonio Nateras
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-11909-3

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine